1584642-06-7Relevant articles and documents
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathies
Lou, Kevin,Yao, Yuemang,Hoye, Adam T.,James, Michael J.,Cornec, Anne-Sophie,Hyde, Edward,Gay, Bryant,Lee, Virginia M.-Y.,Trojanowski, John Q.,Smith, Amos B.,Brunden, Kurt R.,Ballatore, Carlo
, p. 6116 - 6127 (2014/08/18)
Microtubule (MT) stabilizing drugs hold promise as potential treatments for Alzheimer's disease (AD) and related tauopathies. However, thus far epothilone D has been the only brain-penetrant MT-stabilizer to be evaluated in tau transgenic mice and in AD p
HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE TAUOPATHIES
-
Paragraph 0101; 0102; 0136, (2014/04/04)
The present invention is directed to triazolopyrimidine, phenylpyrimidine, pyridopyridazine, and pyridotriazine compounds and their use in the treatment of neurodegenerative disorders.